Autologous Bone Marrow Transplantation (ABMT) in the Treatment of Cancer

References

• Pegg DE: Autologous bone marrow transplantation in man. In Bone Marrow Transplantation. Lloyd-Luke Ltd, London, 1966, pp 113–124.
   Google Scholar
• Graze PR, Gale RP: Autotransplantation for leukemia and solid tumors. Transplant Proc 10:177–184, 1978.
   PubMed Web of Science ®Google Scholar
• Deisseroth A, Abrams RA: The role of autologous stem cell reconstitution in the intensive therapy of resistant meoplasms. Cancer Treat Rep 63:461–471, 1979.
   PubMedGoogle Scholar
• Tobias JS, Tattersal MNH: Perspectives in cancer research: Autologous marrow support and intensive chemotherapy in cancer patients. Eur J Cancer 12:1–8, 1976.
   PubMed Web of Science ®Google Scholar
• Kaizer H, Santos GW: Autologous bone marrow transplantation in treatment of leukemia, lymphomas, and other cancers. In Progress in Clinical Cancer, Ariel lM, Ed: Grune & Stratton. New York, 1982, 31–43.
   Google Scholar
• Vogler WR, Winton EF: Autologous marrow transplantation: Current status and future directions. In Progress in Clinical Cancer, Ariel 1M, Ed: Grune & Stratton, New York, 1982, Vol VIII, pp 45–56.
   Google Scholar
• Herzig GP: Autologous marrow transplantation in cancer therapy. Prog Hematol 12: 1-23, 1981.
   Google Scholar
• Weiden PL, Flournoy N, Thomas ED, et al: Anti-leukemic effects of graft-versus-host disease in human recipients of allogenic marrow grafts, N Engl J Med 300:1068-1073, 1979.
   Google Scholar
• Gale RP: Bone marrow transplantation in acute myelogenous leukemia in 1st remission. Evidence for an antileukemic effect of graft-vs-host disease. Exp Hematol IO(Suppl 11):20 (abstract), 1982.
   Google Scholar
• Rappeport J, Mihm H, Reinherz E, et al: Acute graft-versushost disease in recipients of bone marrow transplants from identical twin donors. Lancet 2:717–720, 1979.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Devergie A, Sohier J, et al:Graft-versus-host disease in recipients of syngeneic bone marrow harvest. Lancet 2:254 (letter), 1979.
   Google Scholar
• Peter A, Cheever MA, Thomas ED, et al: Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twins. Blood 57:421–430, 1981.
   PubMed Web of Science ®Google Scholar
• Zander AR, Dicke KA, Vellekoop L., et al:Autografting in acute leukemia. In Recent Advances in Bone Marrow Transplantation, Gale RP, Ed: Alan R Liss, New York 1983, pp 659–678.
   Google Scholar
• Applebaum FR, Fefer A, Cheever MA, et al: Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twins. Blood 58:509–513, 1981.
   PubMed Web of Science ®Google Scholar
• Phillips GL: Current clinical trials with intensive therapy and autologous bone marrow transplantation for lymphomas and solid tumors, In Recent Advances in Bone Marrow Transplantation, Gale RP, Ed: Alan R Liss, New York 1983, pp 562–597.
   Google Scholar
• Hartmann O, Pein R, Philip T, et al: The effects of high dose polychemotherapy with autologous bone marrow transplantation (ABMT) in 18 children with relapsed lymphoma. Eur J Cancer 18:1044 (abstract), 1982.
   Google Scholar
• Philip T, Biron P, Herve P, et al: Massive BACT Chernotherapy with in 17 cases of non-Hodgkin's malignant lymphoma with a bad prognosis. Eur J Cancer 19:1371–1379, 1983.
   Web of Science ®Google Scholar
• Moore MAS, Williams N, Metcalf D: In vitro colony formation by normal and leukemic human hematopoietic cells, interaction between colony forming and colony stimulating cells. J Natl Cancer Inst 50:591–602, 1973.
   PubMed Web of Science ®Google Scholar
• Hagenbeek A, Martens ACM: Separation of normal hemopoietic stem cells from clonogenic leukemic cells in a rat model for human acute myelocytic leukemia. II. Velocity sedimentation in combination with density gradient separation. Exp Hematol 9(6):573–580, 1981.
   Google Scholar
• Dicke KA, Zander A, Spitzer G, et al: Autologous bone marrow transplantation in relapsing adult leukemia. Exp Hematol 7(Suppl 5):170-182, 1979.
   Web of Science ®Google Scholar
• Dicke KA, Zander A, Spitzer G, et al: Autologous bone marrow transplantation in relapsing adult leukemia. Lancet 1:514–517, 1979.
   PubMed Web of Science ®Google Scholar
• Economou 1S, Shin HA, Kaizer H, et al: Bone marrow transplantation in cancer therapy: Inactivation by antibody and complement of tumor cells in mouse syngeneic marrow transplants. Proc Soc Exp Bioi Med 158: 449-453,1978.23. Thierfelder S, Rodt H, Netzel B: Transplantation of syngeneic bone marrow incubated with leucocyte antibodies. I. Suppression of lymphatic leukemia of syngeneic donor mice. Transplanation 23: 459-463, 1977.
   Google Scholar
• Feeny M, Knopp RC, Greenberger JS, et al: Elimination of leukemic cells from rat bone marrow using antibody and complement. Cancer Res 41:3331–35, 1981.
   PubMed Web of Science ®Google Scholar
• Kaizer H, Wharam MD, Johnson RJ, et al: Requirements for the successful application of autologous bone marrow transplantation in the treatment of selected malignancies. In Haematology and Blood Transfusion: Immunobiology of Bone Marrow Transplantation, Thierfelder S, Rodt H, Kolb HJ, Eds: Springer-Verlag, Berlin, 1980, Vol 25, pp 285–296.
   Google Scholar
• Vitetta ES, Krolick KA, Miyama-Inaba M, et al: Immunotoxins: A new approach to cancer therapy. Science 219:644–296, 1973.
   Google Scholar
• Thorpe PE, Detre SI, Mason AJ, et al: Monoclonal antibody therapy: “Model” experiments with toxin-conjugated antibodies in mice and rats. In Haematology and Blood Transfusion: Modern Trends in Human Leukemia. V. Neth R, Gallo RC, Greaves MF, Moore MAS, Winkler K, Eds: SpringerVerlag, Berlin, 1983, Vol 28, pp 107–111.
   Google Scholar
• Friedman OM, Miles A, Colvin OM Cyclophosphamide and related phosphoramide mustards. In Advances in Cancer Chemotherapy, Rosowsky A, Ed: Marcel Dekker, New York, 1979, pp 143–204.
   Google Scholar
• Sharkis SJ, Santos GW, Colvin OM: Elimination of acute myelogenous leukemia cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide. Blood 55:521–523, 1980.
   PubMed Web of Science ®Google Scholar
• Santos GW, Sharkis SJ: Experience with syngeneic marrow transplanation in BN and WF rat models of acute myelogenous leukemia. In Experimental Hematology Today, Baum SJ, Ledney GD, Eds: Springer-Verlag, New York, 1978, pp 187–193.
   Google Scholar
• Kaizer H, Cote JP, Sharkis S, et al: Autologous bone marrow transplantation in acute leukemia: The use of in vitro incubation of tumor-marrow mixtures with 4-hydroperoxycyphosphamide (4HC) in a Wistar-Furth rat model of acute myelogenous leukemia (WF-AML). Proc Am Assoc Cancer Res 23:194 (abstract), 1982.
   Google Scholar
• Stiff PJ, Wustrow T, DeRisi M, et al: An in vivo murine model of bone marrow (BM) purification of tumor by VP-16-213. Blood 60(Suppl 1):17a (abstract), 1982.
   Google Scholar
• Sieber F, Meagher RC, Spivak JL: Differential sensitivity of mouse hematopoietic stem cells in meroyanine 540. Differentiation 19:65–67, 1981.
   PubMed Web of Science ®Google Scholar
• Sieber F, Stuart RK, Sensenbrenner LL, et al: Susceptibility to merocyanin 540-mediated photosensitization preferentially inhibits in vitro colony formation by two human leukemia cell lines. Clin Res 30:331A (abstract), 1982.
   Google Scholar
• Sieber F, Meagher nc, Sutcliffe AM, et al: Purging of leukemic cells from bone marrow grafts by merocyanine 540-mediated photosensitization. Clin Res 31:412A (abstract), 1983.
   Google Scholar
• Netzel B, Rodt H, Haas RJ, et al: Autologous marrow transplantation in childhood acute lymphoblastic leukemia: Elimination of leukemic cells from the graft by antileukemia antibodies. Exp Hematol 9(Suppl 9):142 (abstract), 1981.
   Google Scholar
• Mitsuyasu R, Champlin R, Wells J, et al: Autologous bone marrow transplantation after in vitro marrow treatment with anti-calla heteroantiserium and complement. In Recent Advances in Bone Marrow Transplantation, Gale RP, Ed: Alan R Liss, New York, 1983, pp 679–687.
   Google Scholar
• Wells JR, Billing R, Herzog P, et al: Autotransplantation after in vitro immunotherapy of lymphocytic leukemia. Exp Hematol 7:164–169, 1979.
   PubMed Web of Science ®Google Scholar
• Kaizer H, Levy R, Cote JP, et al: Autologous bone marrow transplantation in lymphoblastic lymphoma and T-cell leukemia. Blood 60(Suppl 1):169c (abstract), 1982.
   Google Scholar
• Sallan S, Bast R, Lipton J, et al: Autologous bone marrow transplantation in childhood acute lymphoblastic leukemia. Blood 60(Suppl 1): I72a(abstract), 1983.
   Google Scholar
• Sallan SE, Bast RC Lipton J, Lowenberg B, Hagenbeek A, Eds: Martinus Nijhoff, The Hague, in press.
   Google Scholar
• Herve P, Tamyo E, Lamy B, et al: In vitro treatment of autologous marrow cells collected in leukaemia patients using cyclophosphamide derivative. Exp Hematol II(Suppl 14):10 (abstract), 1983.
   Google Scholar
• Kaizer H, Stuart RK, Fuller DJ, et al: Autologous bone marrow transplantation in acute leukemia: progress report on a phase I study of 4-hydroperoxycyclophosphamide (4HC) incubation of marrow prior to cryopreservation. Am Soc Clin Oncol 1:131 (abstract), 1982.
   Google Scholar
• Hilderbrand J, Badjou R, Collard-Ronge E, et al: Treatment of brain gliomas with high dose CCNU and autologous bone marrow transplantation. Biomedicine 32:71–75, 1980.
   PubMedGoogle Scholar
• Carella AM, Giordano D, Santini G, et al: High dose BCND followed by autologous bone marrow infusion glioblastoma multiforme. Tumori 67:473–475, 1981.
   PubMed Web of Science ®Google Scholar
• Hockberg FH, Parker LM, Takvorian T, et al: High dose BCNU with autologous bone marrow rescue for recurrent gliblastoma multiforme. J Neurosurg 54:455–461, 1981.
   PubMed Web of Science ®Google Scholar
• Spitzer G, Dicke KA, Verma DS, et al: High-dose BCNU therapy with autologous bone marrow infusion: Preliminary observations. Cancer Treat Rep 63: [257-1264, 1979.
   Google Scholar
• Spitzer G, Dicke KA, Litam J, et al: High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors. Cancer 45:3075–3085, 1980.
   PubMed Web of Science ®Google Scholar
• Souhami RL, Harper PG, Linch D, et al: High-dose cyclophosphamide with autologous marrow transplantation forsmall cell carcinoma of the bronchus. Cancer Chemother Pharmacal 10:205–207, 1983.
   PubMed Web of Science ®Google Scholar
• Glode ML, Robinson WA, Hartmann OW, et al: Autologous bone marrow transplantation in the therapy of small cell carcinoma of the lung. Cancer Res 42:4270–4275, 1982.
   PubMed Web of Science ®Google Scholar
• Harada M, Yoshida T, Ishino FC, et al: Combined-modality therapy and autologous bone marrow transplantation in the treatment of advanced non-Hodgkin's lymphoma and solid tumor: The Kanazawa experience. Transplant Proc 4:733–737, 1982.
   Google Scholar
• Douer D, Champlin RE, Ho WG, et al: High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancer. Am J Med 71:973–976, 1981.
   PubMed Web of Science ®Google Scholar
• Zander A, Spitzer G, Legha S, et al: High-dose AMSA and bone marrow rescue in patients with solid tumors. Cancer Treat Rep 66:385–386, 1982.
   PubMedGoogle Scholar
• Barbasch A, Higby OJ, Brass C, et al: High-dose cytoreductive therapy with autologous bone marrow transplantation in advanced malignancies. Cancer Treat Rep 67:143–148, 1983.
   PubMedGoogle Scholar
• McElwain TJ, Hedley OW, Burton G, et al: Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. Br J Cancer 40:72–80, 1979.
   PubMed Web of Science ®Google Scholar
• Lazarus HM, Herzig RH, Graham-Pole J, et al: Intensive melphalan chemotherapy and cyropreserved autologous bone marrow transplantation in the treatment of refractory cancer. J Clin Oncol 6:359–367, 1983.
   Google Scholar
• Herzig RH, Lazarus HM, Graham-Pole J, et al: Autologous bone marrow transplantation for malignant diseases: A phase 1-11 study for melanoma, neuroblastoma, Ewing's sarcoma and germ cell tumors using high-dose melphalan. In Recent Advances in Bone Marrow Transplantation, Gale RP, Ed: Alan R Liss, New York, 1983, pp 643–657.
   Google Scholar
• Thomas RM, Robinsson WA, Glode LM, et al: Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results-Phase I study. Am J Clin Oncol 5:611–622, 1982.
   PubMed Web of Science ®Google Scholar
• Thomas MR, Robinson WA, Murghal T, et al: Autologous bone marrow transplantation and high dose chemotherapy in advanced malignant melanoma phase I study. ASCO Abstr C-947:243 (abstract), 1983.
   Google Scholar
• Hartmann OW, Robinson WA, Morton NJ, et al: High-dose nitrogen mustard (HN2) with autologous nonfrozen bonemarrow transplantation in advanced malignant melanoma. Blut 42:209–220, 1981.
   PubMedGoogle Scholar
• Sarna GP, Champlin R, Wells J, et al: Phase I study of highdose mitomycin with autologous bone marrow support. Cancer Treat Rep 66:277–282, 1982.
   PubMedGoogle Scholar
• Blijham G, Spitzer G, Litam J, et al: The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow support. Eur J Cancer 17:433–441, 1981.
   PubMed Web of Science ®Google Scholar
• Gorin NC, David R, Stachowiak J, et al: High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. Eur J Cancer 17:557–568, 1971.
   Google Scholar
• Pritchard J, McElwain TJ, Graham-Pole J: High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 45:86–94, 1982.
   PubMed Web of Science ®Google Scholar
• Gulati S, Helson L, Langleben A, et al: Therapy of disseminated neuroblastoma with intensive therapy and autologous stem cell rescue. Eur J Cancer Clin Oncol 18 (8):1043 (abstract), 1982.
   Google Scholar
• Ramsay N, Woods W, Krivit W, et al: Bone marrow transplantation (BMT) for children with stage IV neuroblastoma: A pilot study at the University of Minnesota. Eur J Cancer Clin Oncol 18 (8):1039 (abstract) 1982.
   Google Scholar
• August CS, Serota FT, Koch PA, et al: Bone marrow transplantation for relapsed stage IV neuroblastoma. In Recent Advances in Bone Marrow Transplantation. Gale RP, Ed: Alan R Liss, New York, 1983, pp 703–716.
   Google Scholar
• Tannir N, Spitzer G, Schell F, et al: Phase II study of highdose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer. Cancer Treat Rep 6:599–600, 1983.
   Google Scholar
• Stewart PS: Autologous bone marrow transplantation in metastatic breast cancer. Breast Cancer Res Treat 2:85–92, 1982.
   Google Scholar
• Cornbleet MA, Corringham RET, Prentice HG, et al: Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation. Cancer Treat Rep 65:241–244, 1981.
   PubMedGoogle Scholar
• Dunn CDR: The effect of certain nitrogen mustard derivatives on bone marrow colony-forming units and repopulating ability: I. Rats. Eur J Cancer 8: 509-516, 1972.
   Google Scholar